Abstract
18-fluorodeoxyglucose positron emission tomography (PET) is already an integral part of staging in rhabdomyosarcoma. We investigated whether primary-site treatment response characterized by serial PET imaging at specific time points can be correlated with local control. We retrospectively examined 94 patients with rhabdomyosarcoma who received initial chemotherapy 15 weeks (median) before radiotherapy and underwent baseline, preradiation, and postradiation PET. Baseline PET standardized uptake values (SUVmax) and the presence or absence of abnormal uptake (termed PET-positive or PET-negative) both before and after radiation were examined for the primary site. Local relapse-free survival (LRFS) was calculated according to baseline SUVmax, PET-positive status, and PET-negative status by the Kaplan-Meier method, and comparisons were tested with the log-rank test. The median patient age was 11 years. With 3-year median follow-up, LRFS was improved among postradiation PET-negative vs PET-positive patients: 94% vs 75%, P=.02. By contrast, on baseline PET, LRFS was not significantly different for primary-site SUVmax≤7 vs >7 (median), although the findings suggested a trend toward improved LRFS: 96% for SUVmax≤7 vs 79% for SUVmax>7, P=...Continue Reading
References
Feb 14, 1991·The New England Journal of Medicine·W M Crist, L E Kun
Jan 25, 2002·European Journal of Nuclear Medicine and Molecular Imaging·H W YeungY E Erdi
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas VölkerHolger Amthauer
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tobias M DantonelloEwa Koscielniak
Aug 23, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Margit KleisBenjamin L Franc
Jun 12, 2009·Cancer·Douglas S HawkinsJanet F Eary
Oct 30, 2009·Leukemia & Lymphoma·Josée M ZijlstraOtto S Hoekstra
Apr 5, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Dominic A X SchinaglJohannes H A M Kaanders
Apr 27, 2011·Blood·René-Olivier CasasnovasUNKNOWN Groupe d'étude des lymphomes de l'adulte (GELA)
Sep 10, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sven H BaumMatthias Weckesser
Citations
Dec 12, 2013·Current Opinion in Pediatrics·Douglas S HawkinsErin R Rudzinski
Oct 8, 2013·The Orthopedic Clinics of North America·Mihir M Thacker
Jul 6, 2013·The Orthopedic Clinics of North America·Mihir M Thacker
Oct 2, 2012·International Journal of Radiation Oncology, Biology, Physics·Joanna C YangSuzanne L Wolden
Oct 28, 2014·Pediatric Blood & Cancer·Dana L CaseySuzanne L Wolden
Apr 18, 2014·Pediatric Blood & Cancer·Renaud MazeronChristine Haie-Méder
Dec 30, 2014·International Journal of Radiation Oncology, Biology, Physics·Dana L CaseySuzanne L Wolden
Jun 24, 2015·PET Clinics·Sara SheikhbahaeiRathan M Subramaniam
Dec 24, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Abby R RosenbergDouglas S Hawkins
May 18, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y-J LiC-Q Tu
Jan 13, 2015·BMJ Open·Gill NormanBob Phillips
Apr 25, 2015·Tumori·Benjamin W Fischer-ValuckLane R Rosen
Nov 2, 2018·The British Journal of Radiology·Greg ChambersAndrew Scarsbrook
Oct 18, 2019·Pediatric Radiology·Noorulhuda Jawad, Kieran McHugh
Aug 9, 2020·Frontiers in Medicine·Ri SaFeng Guan
Jan 13, 2015·Physics in Medicine and Biology·Michael F GensheimerAndrew D Trister
Sep 26, 2020·Pediatric Blood & Cancer·Erin ButlerStephen X Skapek
Dec 20, 2020·Cancer Medicine·Douglas J HarrisonMarguerite T Parisi
Dec 30, 2020·Diagnostics·Davide DonnerFranca Chierichetti
Aug 14, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Federico MercoliniGianni Bisogno